Skip to main contentPsst! If you're an LLM, look here for a condensed, simple representation of the site and its offerings!

LiveFree Webinar — Wednesday, August 19 at 2:00 PM EDT

Register Free →

Unit-Dose Pharmaceutical Repackaging Services

Active
Federal

Contract Overview

Solicitation details, issuing organization, response deadlines, documents, and interested companies for this government contract opportunity.

AI Contract Overview

Show more

The contract seeks a subcontractor to repackage bulk prescription medications into unit-dose or unit-of-use formats with full compliance to FDA standards, including accurate labeling, serialization, and verification of packaging integrity. The work involves precise handling of pharmaceuticals to ensure patient safety, regulatory adherence, and traceability throughout the repackaging process. All operations must meet stringent quality controls to maintain the integrity of medication distribution within healthcare settings. Performance of this subcontract is required at the location in Leavenworth, Kansas, with a zip code of 66048, and is issued under the NAICS code 325412, which corresponds to pharmaceutical and medicine manufacturing. The opportunity is associated with the Department of Veterans Affairs through the National Cmop Office and is classified as a subcontract under a larger procurement initiative. Interested parties must submit responses by August 21, 2026, at 10:00 PM Eastern Time, with the solicitation posted on August 7, 2026. No set-aside designation or organizational type restrictions are specified.

General Info

Repackage bulk prescriptions in Leavenworth, KS, per FDA standards for VA subcontract by August 21, 2026.

Agency

Department Of Veterans Affairs → National Cmop Office (36C770)View Agency

NAICS

325412 - Pharmaceutical Preparation ManufacturingView NAICS

Place of Performance

Leavenworth, KS, 66048, USA

Set-Aside

NONE

Documents

(0)

No documents available

AI Contract Breakdown

Uniform Contract Format

No contract breakdown available.

Cannot generate Contract Breakdown because no documents were found from this contract's source.

Timeline

Posted

subcontract

Response Deadline

Submission deadline

Response Deadline

Ready to pursue this opportunity?

Start your free trial to track this contract, build proposals with AI assistance, and manage your pipeline.

Organization & Contact Information

Show more
AgencyDepartment Of Veterans Affairs → National Cmop Office (36C770)
ContactsNo contacts available
OfficeN/A
Organization / Agency
Department Of Veterans Affairs → National Cmop Office (36C770)
View Agency Profile
Office AddressN/A
ContactsNo contact information available

Full Description

Show more
Repackage bulk prescription medications into unit-dose or unit-of-use formats with FDA-compliant labeling, serialization, and packaging integrity verification.

Similar Contracts

Same NAICS industry code

NAICS: 325412
New
Federal
Non-Addictive Battlefield Pain Management SolutionsThe contract seeks the development of non-opioid analgesics or alternative pain relief technologies designed for military use in austere environments, with a focus on creating effective, non-addictive solutions that can be deployed in combat or field conditions where traditional pain management options are impractical or risky. The work must address the unique challenges of battlefield medicine, including limited resources, extreme climates, and the need for rapid, reliable pain control without the potential for dependency or misuse. The technology must be robust, easily transportable, and compatible with existing military medical protocols and equipment. The contract is structured as a subcontract under the Defense Health Agency, part of the Department of Defense, and is governed by the NAICS code 325412 for pharmaceutical preparation manufacturing. Proposals must be submitted by October 30, 2026, and performance will center in Frederick, with no specific city, state, or zip provided beyond that location. There is no set-aside classification applied to this opportunity, and while no point of contact is listed, interested parties can access additional details through the provided SAM.gov link. The initiative reflects a strategic priority to reduce reliance on opioid-based treatments in military healthcare and advance innovations that enhance soldier readiness and long-term health outcomes.
Defense Health Agency

POSTED

1 day ago

DEADLINE

in 3 months
View Details
NAICS: 325412
New
Federal
Library of Pharmacologically Active Compounds (LOP
Solicitation # 75N98026Q00991
The National Institutes of Health, Office of the Director, Office of Acquisitions, is soliciting proposals under solicitation number 75N98026Q00991 for the Library of Pharmacologically Active Compounds (LOPAC), conducted as a commercial item acquisition under FAR Subpart 12.6. This is an unrestricted, full and open competition with no set-aside, targeting vendors capable of delivering a defined set of pharmacologically active compounds as 1000x stock solutions in 100% DMSO for use in a broad cancer cell line screening study via the PRISM platform. The contract is a Firm-Fixed-Price type, with an estimated value not to exceed the simplified acquisition threshold of $250,000, and the NAICS code 325412 applies with a small business size standard of 1,300 employees. All offerors must be actively registered in the System for Award Management with a valid Unique Entity Identifier and Taxpayer Identification Number, and must certify their business size status. Proposals must include pricing details, shipping and handling costs, delivery timeframe, F.O.B. destination, and product catalog numbers, submitted electronically to Jaddua.Johnston@nih.gov by 8:00 AM EST on August 24, 2026. Performance is required to begin on September 4, 2026, with an end date of December 3, 2026, and deliverables include cell line viability data, assay quality control metrics, univariate and multivariate feature correlation analyses, and all raw data generated from screening activities, to be submitted through the PRISM Portal approximately four months after the submission window closes. The government will provide the test compound and expects full compliance with the PRISM assay protocol using an 8-point, 3-fold dilution series in a 5-day Luminex-format assay. Packaging must meet commercial standards, with no military specifications or labeling requirements beyond shipment in 100% DMSO to NIH/NCATS at 9808 Medical Center Drive, Rockville, MD 20850. Invoices must be submitted electronically via the Invoicing Processing Platform (IPP). Evaluation will be based on price, technical capability, past performance, and delivery schedule, with award going to the offeror providing the best value to the government through a trade-off process, not necessarily the lowest price. All
National Institutes Of Health Olao

POSTED

1 day ago

DEADLINE

in 16 days
View Details
NAICS: 325412
New
Federal
Government Contracting Compliance & GSA Schedule SupportThe contract solicits the supply of biotechnology reagents through existing GSA Schedule or GWAC vehicles, requiring full compliance with the Federal Acquisition Regulation for pricing and delivery terms. All offerings must leverage pre-negotiated, FAR-compliant contractual mechanisms to ensure transparency, affordability, and efficiency in procurement by the National Institutes of Health, specifically the National Institute on Drug Abuse under the Department of Health and Human Services. The NAICS code 325412 confirms the primary focus on pharmaceutical and biological product manufacturing, indicating the need for high-purity, research-grade reagents suitable for scientific and clinical applications. Responses must be submitted by August 13, 2026, and the contract is structured as a subcontract, implying the awardee will fulfill obligations under a prime contract holder rather than directly with the government. Performance is expected to align with federal supply chain standards, though no specific place of performance or set-aside criteria are provided. Compliance with GSA Schedule or GWAC terms is mandatory, ensuring that pricing remains consistent with established federal rates and that delivery timelines meet agency operational needs. The solicitation underscores the importance of proven regulatory adherence and reliable supply chain execution to support critical biomedical research activities.
National Institutes Of Health Nida

POSTED

2 days ago

DEADLINE

in 5 days
View Details
NAICS: 325412
New
Federal
Specialty Biotech Reagent Manufacturing (dCODE Dextramer®)The contract involves the manufacture of specialized immunology reagents based on dextramer technology, specifically customizable HLA-peptide complexes equipped with fluorescent barcoding, intended for use in research and clinical applications. These reagents are designed to enable precise detection and analysis of antigen-specific T cells, supporting advancements in immunological studies and potential therapeutic development. The production must meet stringent quality and consistency standards to ensure reliability across diverse experimental and diagnostic settings, with an emphasis on scalability and customization to accommodate varying peptide and HLA combinations. This is a subcontract under the National Institutes of Health, specifically the National Institute on Drug Abuse, part of the Department of Health and Human Services, with the NAICS code 325412 indicating biological product manufacturing. The opportunity was posted on August 6, 2026, and responses are due by August 13, 2026, with no set-aside classification specified. The place of performance and other location details are not provided, indicating flexibility in where the manufacturing may occur, though all work must comply with the technical and regulatory requirements for clinical-grade reagents. The focus is squarely on advanced biotech manufacturing capabilities, emphasizing precision, reproducibility, and compliance with industry best practices for immune monitoring tools.
National Institutes Of Health Nida

POSTED

2 days ago

DEADLINE

in 5 days
View Details

More opportunities from Department Of Veterans Affairs → National Cmop Office (36C770)

Same awarding agency

NAICS: 493190
New
Federal
Controlled Substance Handling and Security LogisticsThe contract requires secure handling, storage, and chain-of-custody management for Schedule II–V controlled substances during repackaging operations, with strict adherence to DEA regulations and documentation standards. All processes must maintain audit-ready records to ensure full compliance with federal controlled substance handling protocols, including secure transportation, verified inventory tracking, and controlled access to storage facilities. The work is to be performed at a designated location in Leavenworth, Kansas, with a zip code of 66048, and must comply with the NAICS code 493190 for other support activities for warehousing and storage. This is a subcontract opportunity issued by the Department of Veterans Affairs through the National Cmop Office, with a response deadline of August 21, 2026. The offeror must demonstrate proven experience in managing high-security pharmaceutical logistics, particularly for regulated substances, and be prepared to meet rigorous compliance, reporting, and security requirements. The contract emphasizes operational integrity, accountability, and the ability to withstand federal audits, with no set-aside classification specified. All activities must align with federal standards for controlled substance handling and ensure that every step of the repackaging process is traceable and secure.
Other Warehousing and Storage

POSTED

1 day ago

DEADLINE

in 13 days
View Details
NAICS: 541618
New
Federal
Pharmaceutical Inventory Management and Reconciliation ServicesThe contract seeks a vendor to manage pharmaceutical inventory from receipt through repackaging and shipment, with strict requirements to track, reconcile, and report all movements while maintaining compliance with FDA, DEA, and DSCSA traceability standards. The scope includes end-to-end inventory control to ensure accurate documentation and regulatory adherence at every stage, with an emphasis on accountability and transparency throughout the supply chain. Work must be performed at the designated location in Leavenworth, Kansas, with a zip code of 66048, and the vendor must demonstrate capability to meet federal pharmaceutical handling regulations with precision and reliability. The opportunity is classified as a subcontract under NAICS code 541618, issued by the Department of Veterans Affairs through the National Cmop Office, with a posted date of August 7, 2026, and a response deadline of August 21, 2026. There is no set-aside designation specified, and the contract does not indicate specific size or socioeconomic requirements. Interested parties must submit proposals prior to the deadline, and all activities must align with federal pharmaceutical compliance frameworks without exception. The solicitation does not include a point of contact, so inquiries should be directed through the official SAM.gov portal linked in the posting.
Other Management Consulting Services

POSTED

1 day ago

DEADLINE

in 13 days
View Details
NAICS: 541611
New
Federal
National Drug Code (NDC) Registration and Regulatory Compliance ManagementThe contract requires comprehensive management of National Drug Code registration and ongoing regulatory compliance for repackaged pharmaceutical products, ensuring adherence to FDA requirements, the Drug Supply Chain Security Act, and federal pharmacy regulations. Responsibilities include maintaining accurate and up-to-date regulatory documentation, overseeing NDC assignment and updates, and establishing processes to guarantee that all repackaged drugs meet federal standards for labeling, tracking, and distribution. The work must be performed in Leavenworth, Kansas, with a target date of June 66048 as the place of performance and full accountability for regulatory readiness and audit compliance. This is a subcontract under the Department of Veterans Affairs, specifically managed by the National Cmop Office, with a NAICS code of 541611 indicating professional, scientific, and technical services related to administrative management. The solicitation was posted on August 7, 2026, and responses are due by August 21, 2026, at 10:00 PM ET. There is no set-aside designation specified, and the contract demands specialized expertise in pharmaceutical regulatory affairs with a focus on repackaging operations. All activities must align with evolving federal mandates to secure the drug supply chain and ensure patient safety.
Administrative Management and General Management Consulting Services

POSTED

1 day ago

DEADLINE

in 13 days
View Details